Originally discovered and developed by Eli Lilly , oritavancin was acquired by InterMune in 2001 and then by Targanta Therapeutics in late 2005 .
Originally taken over by Eli Lilly , oritavancin was discovered and developed by InterMune in 2001 and in late 2005 by Targanta Therapeutics .